Related Experiment Videos
Characterization of pseudotype VSV possessing HCV envelope proteins
1Research Center for Emerging Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. matsuura@biken.osaka-u.ac.jp
Virology
|August 4, 2001
Summary
Both hepatitis C virus (HCV) envelope glycoproteins, E1 and E2, are essential for maximal viral infection. Cell surface proteins and glycosaminoglycans are crucial for HCV entry into cells.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Hepatitis C virus (HCV) entry into host cells is mediated by its envelope glycoproteins, E1 and E2.
- Understanding the specific roles of E1 and E2 in viral entry is critical for developing antiviral strategies.
Purpose of the Study:
- To investigate the roles of HCV envelope glycoproteins E1 and E2 in viral infection.
- To identify host cell surface molecules involved in HCV entry.
Main Methods:
- HCV-VSV pseudotypes were generated using chimeric E1 and E2 glycoproteins.
- Infectivity was assessed by quantifying GFP reporter gene expression in HepG2 cells.
- Inhibition assays were performed using antibodies, bovine lactoferrin, and enzymes (Pronase, heparinase, heparitinase).
Main Results:
- Pseudotypes containing both E1 and E2 showed 10-20 times higher infectivity than those with individual glycoproteins.
- Bovine lactoferrin inhibited pseudotype infection.
- Enzymatic treatments indicated that cell surface proteins and glycosaminoglycans are important for HCV entry.
Conclusions:
- Both HCV E1 and E2 glycoproteins are required for efficient viral infection.
- Cell surface proteins and glycosaminoglycans play significant roles in HCV binding and/or entry.
- HCV-VSV pseudotypes are a valuable tool for studying HCV receptors and developing therapeutics.